Open AccessSafe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling
Author(s) -
Sanjay Kalra,
Amna Aamir,
M. F. Amin,
Sarita Bajaj,
Uditha Bulugahapitiya,
Ashok Kumar Das,
Sabyasachi Ghosh,
Sonali Gunatilake,
Saeed Ahmed Mahar,
Nadeem Qureshi,
Syed Abbas Raza,
Dina Shrestha,
Noel Somasundaram,
Manilka Sumanatilleke,
A. Wijesinghe
Publication year - 2016
Publication title -
sri lanka journal of diabetes endocrinology and metabolism
Language(s) - English
Resource type - Journals
ISSN - 2012-998X
DOI - 10.4038/sjdem.v6i2.7316
Subject(s) - sri lanka , medicine , diabetes mellitus , endocrine system , endocrinology , transporter , family medicine , carbohydrate metabolism , gynecology , biochemistry , south asia , biology , anthropology , sociology , gene , hormone
Diabetes management is a complex process and optimal therapeutic outcomes are achieved with patientcentered multi-disciplinary care (1). This includes non-pharmacological and pharmacological interventions and also the counselling. Diabetes counselling is a vast concept, which covers many aspects of diabetes care, including medication counselling, and this is distinct from diabetes education (2). through a process of informed and shared decision making. In diabetes, some topics of counselling are common to all classes of glucoselowering drugs, while some are unique to specific classes or molecules (4).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom